476 related articles for article (PubMed ID: 25755608)
21. Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma.
Paul SB; Sharma H
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S112-21. PubMed ID: 25755602
[TBL] [Abstract][Full Text] [Related]
22. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
Jearth V; Patil PS; Mehta S; Sundaram S; Seth V; Goel M; Patkar S; Bal M; Rao V
J Clin Exp Hepatol; 2022; 12(3):841-852. PubMed ID: 35677513
[TBL] [Abstract][Full Text] [Related]
23. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
[TBL] [Abstract][Full Text] [Related]
24. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
25. What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association.
Allaire M; Bruix J; Korenjak M; Manes S; Maravic Z; Reeves H; Salem R; Sangro B; Sherman M
JHEP Rep; 2022 Dec; 4(12):100578. PubMed ID: 36352896
[TBL] [Abstract][Full Text] [Related]
26. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.
Puri P; Anand AC; Saraswat VA; Acharya SK; Sarin SK; Dhiman RK; Aggarwal R; Singh SP; Amarapurkar D; Arora A; Chhabra M; Chetri K; Choudhuri G; Dixit VK; Duseja A; Jain AK; Kapoor D; Kar P; Koshy A; Kumar A; Madan K; Misra SP; Prasad MV; Nagral A; Puri AS; Jeyamani R; Saigal S; Shah S; Sharma PK; Sood A; Thareja S; Wadhawan M
J Clin Exp Hepatol; 2014 Jun; 4(2):117-40. PubMed ID: 25755549
[TBL] [Abstract][Full Text] [Related]
27. Value of Gd-EOB-DTPA-Enhanced MRI and Diffusion-Weighted Imaging in Detecting Residual Hepatocellular Carcinoma After Drug-Eluting Bead Transarterial Chemoembolization.
Liu HF; Xu YS; Liu Z; Che KY; Sheng Y; Ding JL; Zhang JG; Lei JQ; Xing W
Acad Radiol; 2021 Jun; 28(6):790-798. PubMed ID: 32414638
[TBL] [Abstract][Full Text] [Related]
28. Liver Transplantation: East versus West.
Shukla A; Vadeyar H; Rela M; Shah S
J Clin Exp Hepatol; 2013 Sep; 3(3):243-53. PubMed ID: 25755506
[TBL] [Abstract][Full Text] [Related]
29. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
31. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
32. Survival and Outcome in Patients Receiving Drug-Eluting Beads Transarterial Chemoembolization for Large Hepatocellular Carcinoma (>5 cm).
Mukund A; Bhardwaj K; Choudhury A; Sarin SK
J Clin Exp Hepatol; 2021; 11(6):674-681. PubMed ID: 34866846
[TBL] [Abstract][Full Text] [Related]
33. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.
Nahon P; Najean M; Layese R; Zarca K; Segar LB; Cagnot C; Ganne-Carrié N; N'Kontchou G; Pol S; Chaffaut C; Carrat F; Ronot M; Audureau E; Durand-Zaleski I; ; ; ;
JHEP Rep; 2022 Jan; 4(1):100390. PubMed ID: 34977518
[TBL] [Abstract][Full Text] [Related]
34. Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.
Gupta V; Kumar A; Sharma P; Bansal N; Singla V; Arora A
J Clin Exp Hepatol; 2015 Jun; 5(2):134-41. PubMed ID: 26155041
[TBL] [Abstract][Full Text] [Related]
35. Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.
Tohra S; Duseja A; Taneja S; Kalra N; Gorsi U; Behera A; Kaman L; Dahiya D; Sahu S; Sharma B; Singh V; Dhiman RK; Chawla Y
J Clin Exp Hepatol; 2021; 11(6):682-690. PubMed ID: 34866847
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Cerban R; Ester C; Iacob S; Paslaru L; Dumitru R; Grasu M; Constantin G; Popescu I; Gheorghe L
Chirurgia (Bucur); 2018; 113(4):524-533. PubMed ID: 30183583
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection.
Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
Aliment Pharmacol Ther; 2021 Jun; 53(12):1309-1316. PubMed ID: 33896023
[TBL] [Abstract][Full Text] [Related]
38. Living donor liver transplantation for hepatocellular carcinoma.
Lee SG; Moon DB
Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
[TBL] [Abstract][Full Text] [Related]
39. Tissue diagnosis of hepatocellular carcinoma.
Jain D
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S67-73. PubMed ID: 25755614
[TBL] [Abstract][Full Text] [Related]
40. Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantation.
Schumacher PA; Powell JJ; MacNeill AJ; Buczkowski AK; Erb SR; Ho SG; Scudamore CH; Steinbrecher UP; Weiss A; Yoshida E; Chung SW
Ann Hepatol; 2010; 9(1):23-32. PubMed ID: 20308719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]